NEUPOGEN (Amgen Inc)
Welcome to the PulseAid listing for the NEUPOGEN drug offered from Amgen Inc. This Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | Filgrastim |
| SUBSTANCE NAME: | FILGRASTIM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2000-10-02 |
| END MARKETING DATE: | 0000-00-00 |
NEUPOGEN HUMAN PRESCRIPTION DRUG Details:
| Item Description | NEUPOGEN from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 480(ug/.8mL) |
| START MARKETING DATE: | 2000-10-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-209_b1bdec6e-58d2-405c-aa15-fdcb8ae2b38c |
| PRODUCT NDC: | 55513-209 |
| APPLICATION NUMBER: | BLA103353 |
Other FILGRASTIM Pharmaceutical Manufacturers / Labelers:
